To examine the upstream regulatory pathway, which is responsible for the anti-cancer properties of SnEA and pyrogallol in CRPC cells, we determined the inhibitory effects of SnEA and pyrogallol on the protein expression levels in the Akt/GSK-3β/β-catenin signaling pathway. This evidence concerns the gene AKT1 and cancer.